primary dysmenorrhea. primary dysmenorrha
Conditions
Interventions
Intervention 1: 250 mg capsule of ginger every 6 hours from two days before the onset of the menstrual period until the first three days of the menstrual period for 3 consequent cycles. Intervention 2
Treatment - Drugs
250 mg capsule of ginger every 6 hours from two days before the onset of the menstrual period until the first three days of the menstrual period for 3 consequent cycles
Ointment 5 drops ginger oil on the abdomen under umbilicus every 6 hours, from two days before the onset of the menstrual period until the first three days of the menstrual period for 3 consequent cyc
Sponsors
School of Traditional Medicine, Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: 18-45 years; BMI = 35; regular menstrual cycles (21-35day) and Regular bleeding (3-10days) in the latest three menses; moderate and severe dysmenorrhea (grade 2,3) based on Multidimensional Verbal Scoring System; rejection of Secondary dysmenorrhea by history and pelvic ultrasound; no History of pelvic or abdominal surgery; not taking other medications; no history of allergy to ginger; no history of bleeding disease; no history of gallstone. Exclusion Criteria: pregnancy; sensitivity to medication during the study; avoiding the correct use of medication; taking another drug that is not defined in the study; patients with Possible serious side effects; patients who need additional interventions and surgery; patients who decide to be excluded.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity. Timepoint: cycle before intervention, every cycles during intervention (3 cycles). Method of measurement: VAS = visual analog scale.;Pain duration. Timepoint: cycle before intervention, every cycles during intervention (3 cycles). Method of measurement: hour. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effect: Stomachache, nasea, vomiting, hematemesis, belch, fatigue, itching, acne, heartburn, diarrhea, constipation, melena,headache, drowsiness, redness, assessment of bleeding with PBAC. Timepoint: cycle before intervention, every cycle during intervention (3 cycles). Method of measurement: questionnaire.;Mefenamic asid use. Timepoint: cycle before intervention, every cycle during intervention (3 cycles). Method of measurement: number. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactPantea Shirooye
School of Traditional Medicine, Shahid Beheshti University of Medical Sciences
Outcome results
None listed